Pappas Capital is a global venture capital and commercial development firm that focuses its investments on next-generation life science, agriculture, and technology companies. Their strategy involves direct venture investments through Pappas Ventures, managing specialized investment funds, and collaborating with research universities to accelerate the development of scientific discoveries into commercial products.
Portfolio
1
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
| Solu Therapeutics | Series A | $41M | Apr 2025 |
Top Co-Investors
Eli Lilly and Company1 shared
Longwood Fund1 shared
DCVC Bio1 shared
Astellas Venture Management1 shared
Alexandria Venture Investments1 shared
Last updated: 3 March 2026